Armata Pharmaceuticals Announces First Quarter 2025 Results and Provides Corporate Update

Go back to Armata Pharmaceuticals Announces First Quarter 2025 Results and Provides Corporate Update

Armata Pharmaceuticals, Inc. (ARMP) Misses Q1 EPS by 4c

May 14, 2025 4:11 PM EDT

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q1 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

... More